Enhancing human regulatory T cells in vitro for cell therapy applications
Adoptive cellular therapies are gaining popularity as a means to treat clinical conditions, with potentially fewer risks and greater efficacy than traditional pharmacological strategies. Regulatory T cells (Tregs) are currently undergoing clinical trials in various immune-mediated pathologies, inclu...
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Journal article |
| Julkaistu: |
Elsevier
2017
|